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Background: Automated breast volume scanner (ABVS) and US elastography (UE) have been useful for the
differentiation of benign and malignant lesions. However, combining these two methods applied in diagnosis of
breast lesions has not yet been reported. The aim of this study is to analyze the inter-examiner reliability of ABVS
and UE, and compare diagnostic performance among ABVS, UE, and the combination of these two methods.
Methods: Forty-one patients (forty-six lesions) underwent both ABVS and UE examinations. ABVS images were
acquired by medial and lateral scans for each breast and classified a BI-RADS category based on the distribution,
size, shape, echogenicity and microcalcification of the lesions. UE images were assigned an elasticity score according
to the distribution of strain induced by light compression. Kappa statistics was used to examine the reproducibility
between examiners with ABVS and UE, and the concordance between pathology and ABVS, UE, and the combination
of these two methods. χ2 test was used to compare diagnostic performance among these three methods.
Two examiners blinded to the patients’ history evaluated the results of breast imaging independently.
Results: Inter-examiner reliability with ABVS (κ = 0.62, 95% confidence interval (CI): 0.44-0.80) and UE (κ = 0.65, 95% CI:
0.48-0.82) was substantial. With respect to the pathology results, the inter-rater coefficient of concordance was κ = 0.81
(95% CI: 0.64-0.98) for ABVS, κ = 0.77 (95% CI: 0.58-0.96) for UE, and κ = 0.90 (95% CI: 0.77-1.00) for combination of ABVS
and UE. Examiner variability was reduced from UE to ABVS, and to the combination of ABVS with UE.
The diagnostic accuracy, sensitivity, and specificity for the combination of ABVS and UE were 95.7% (95%CI: 84.0-99.2),
100% (95% CI: 85.9-100), and 87.5% (95% CI: 60.4-97.8), respectively. When comparing, the diagnostic performance of
ABVS combined with UE was better than, or at least equal to, that of ABVS (accuracy 91.3% (95% CI: 78.3-97.2),
sensitivity 100% (95% CI: 85.0-1.00), specificity 77.8% (95% CI: 51.9-92.6)) or UE (accuracy 89.1% (95% CI: 75.6-95.9),
sensitivity 96.4% (95% CI: 79.8-99.8), specificity 77.8% (95% CI: 51.9-92.6)) alone, though the improvement was no
statistically significance.
Conclusions: Both ABVS and UE demonstrated substantial inter-examiner reliability. With high diagnostic performance
for differentiation of benign and malignant lesions in the breast, the combination of ABVS and UE are useful to improve
the diagnostic accuracy and specificity.
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Table 1 The scoring criteria of UE
Score Chromatic code Possible lesions
1 Entirely pink Prevalently elastic: prevalently
the benign lesions
2 A mosaic pattern of purple
mixed with a small amount
of green
3 A mosaic pattern of green
mixed with a small amount
of yellow
4 Almost the entire lesion in
yellow, but mixed with a
small amount of red
Prevalently rigid: prevalently
the malignant lesions
5 Both the lesion and surrounding
area are red mixed with a small
amount of yellow
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Breast cancer occurs in millions worldwide with an
increasing incidence. According to the American Cancer
Society reported in 2013 [1], the incidence of breast can-
cer is the highest with a mortality the second among all
cancers in the developed regions of the world such as the
European and American countries, while relatively low,
but rising in the developing regions. Detection and diag-
nosis of early stage tumors even microcarcinomas through
innovation of diagnostic technologies may provide reliable
and timely information for clinical treatment [2].
Ultrasonography (US) with the capability of evaluating
breast tissue was first described nearly 60 years ago [3], and
has undergone technical advancements, including Color
Doppler, ABVS, and UE. Especially ABVS and UE, have
become promising methods in detecting breast lesions.
ABVS is in its third decade [4]. It was initially designed
to examine the whole breast with eight probes and a water
tank, but limited by its low resolution [5-7]. With techno-
logical improvement, current ABVS is equipped with a
14 MHz transducer with the capability of scanning the
whole breast automatically [8]. Consequently, the reso-
lution of image is increased by providing better demon-
stration of breast anatomy and proper orientation. And
the operator variability is reduced while the reproducibility
is improved. Furthermore, it is time-saving, requiring only
10 min to scan a breast by a trained medical technologist
[9]. This offers a direct and convenient method for special-
ists to make a diagnosis from images. However, without
substantive breakthrough in diagnosis performance, its
vital role of producing automatic, high-resolution whole
breast imaging cannot replace handheld ultrasonography
(HHUS). Therefore, it is undesirable for clinical practice in
United States. FDA has recommended approval for use in
screening of women with dense breast parenchyma be-
cause it is unsusceptible to breast density [10]. However,
with its striking practical advantages mentioned above,
ABVS is accepted by other countries, and its diagnostic
performance was not inferior to HHUS [11-17].
Nevertheless, ABVS is out of its range when assessing
lesions by stiffness. Instead, US elastography (UE), which
was first described in 1990 [18], may compensate for this
disadvantage. By measuring displacement (strain) within
the tissue produced by compression [19], UE can evaluate
the feature of lesions’ hardness providing additional infor-
mation to distinguish benign from malignant masses with
sensitivity of 78.0%-100% and specificity of 21.0%-98.5%
[20]. Furthermore, UE would increase the sensitivity of
B-mode sonography in detecting metastatic axillary lymph
nodes [21] and distinguishing benign and malignant lesions
associated with microcalcifications detected at screening
mammography [22]. As for image acquisition, compressive
force was required to be appropriate based on algorithm,
which may affect the quality of elastogram [23].The current study is designed to evaluate whether ABVS
combined with UE would provide complementary infor-




41 patients (46 lesions, ages 19–88 years, mean46 ±
1.6 years, 1 male and 40 female) underwent ABVS and UE
at Jinling Hospital from October 2013 to April 2014 were
retrospectively enrolled for the study. The diameter of le-
sions ranged 4.2-62 mm, with a mean 25 ± 2.3 mm. All 46
lesions (18 benign lesions and 28 malignant lesions) from
above 41 patients had ultrasound-guided core needle bi-
opsy to acquire their target breast tissue and then confirm
their pathological type. A panel formalin-fixed paraffin-
embedded breast tumor specimens was obtained from
the archival resource of the Department of Pathology of
Jinling Hospital. Patients without pathological results or
with skin burst, sharp pain, poor compliance were ex-
cluded from the study. All patients signed informed
consent before the ABVS examination, UE examination or
ultrasound-guided core needle biopsy, and the study was
approved by Ethics Committee of Jinling Hospital.
Equipment and data acquisition
ABVS was performed by using ACUSON S2000 ABVS
system (Siemens Medical Solutions, Mountain View,
CA, USA) with a 14 MHz high-frequency linear trans-
ducer, which is capable of acquiring complete image of
the breast (17 × 15 × 6 cm3, 318 two-dimensional slices)
automatically in a single scan in approximately one
minute. Examiners selected the most suitable settings
for patients according to their breast size (A-D and
DD cups), if the breasts were not full enough to contact
with the compression paddle, ultrasound gel was used
to expand contact area. Each breast was routinely scanned
twice (medial and lateral). Patients were in supine position
with slow and shallow breath and the arms above the head
Table 2 Kappa statistics of examiners with ABVS results
ABVS Examiner2
BI-RADS1 BI-RADS2 BI-RADS3 BI-RADS4 BI-RADS5 Total
Examiner1
BI-RADS1 0 0 0 0 0 0
BI-RADS2 0 5 2 0 0 7
BI-RADS3 0 2 4 2 0 8
BI-RADS4 0 0 1 18 0 19
BI-RADS5 0 0 0 5 7 12
Total 0 7 7 25 7 46
κ = 0.62 (95% CI: 0.44-0.80), indicating the inter-examiner reliability reached a substantial agreement.
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tic workstation for reconstructing coronal 3D images.
UE was performed by using the same equipment as for
ABVS. Examiners operated the probe (9 L4 liner trans-
ducer, 4-9 MHz) with light pressure that maintained
contact with skin, and perpendicular to the lesions. The
images were displayed with a scale from pink (softest
component), to green (intermediate component), to red
(hardest component). The compression was indicated to
be just enough when the subcutaneous fat layer ap-
peared as a mix of pink and green and the pectoralis
muscle layer as a mixed of yellow and green. A region of
interest (ROI) needed to be set to center the target




















Invasive ductal carcinoma 27
Invasive cribriform carcinoma 1muscle, and normal mammary glands. Patients were in
supine position with breath holding. The real-time strain
images were acquired after the compression.Images analysis and classification of lesions
ABVS images
Based on the characteristics of the lesions including
the number of lesions, distribution, size, shape (smooth
or irregular), echogenicity (hypoecho, isoecho, or hyper-
echo), and microcalcification, ABVS results were classi-
fied into five categories (0 = incomplete, needing additional
assessment; 1 = normal; 2 = benign; 3 = probably benign;
4 = probably malignant; 5 = highly suggestive of malig-
nancy) according to the American College of Radiologists
Breast Imaging Reporting and Data System (ACR BI-
RADS) [24]. In our study, benign lesions were considered
to be BI-RADS category 1 to 3, and malignant lesions were
category 4 to 5. Interpretation of the images was accom-
plished by two examiners independently who specialized in
ultrasonography more than ten years.Table 4 Kappa statistics of ABVS, UE, and ABVS + UE
results with pathological findings
Results Pathology
Malignant Benign Total
ABVS (κ = 0.81, 95%
CI: 0.64-0.98)
Malignant 28 4 32
Benign 0 14 14
total 28 18 46
UE (κ = 0.77, 95%
CI: 0.58-0.96)
Malignant 27 4 31
Benign 1 14 15
total 28 18 46
ABVS + UE (κ = 0.90,
95% CI: 0.77-1.00)
Malignant 30 2 32
Benign 0 14 14
Total 30 16 46
The inter-rater reliability coefficients of ABVS, UE and ABVS + UE were
calculated.
Table 5 Kappa statistics of examiners with UE results
UE Examiner2
Score1 Score2 Score3 Score4 Score5 Total
Examiner1
Score1 0 0 0 0 0 0
Score2 0 8 1 0 0 9
Score3 0 0 6 1 0 7
Score4 0 0 4 17 5 26
Score5 0 0 0 0 4 4
Total 0 8 11 18 9 46
κ = 0.65 (95% CI: 0.48-0.82), indicating the inter-examiner reliability reached a
substantial agreement.
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In our study, almost all the lesions (one lesion was com-
plex enchogenicity) were hypoechoic. We only compared
the color mode in the lesions with surrounding breast
tissue, assigning each image an elasticity score on a
five-point scale. Generally, the higher share of blue color
represent the harder lesion and the lower share of red
color represent the softer lesion displayed in elasticity
image. However, the color mode of Siemens free-hand
elasticity software can be inversed as red indicating hard
lesions whereas pink indicating soft lesions. Therefore,
the scoring criteria were showed in Table 1. The score
1–3 were classified as benign, and score 4–5 classified asFigure 1 US, UE, ABVS and histologic section image in a 51-year-old w
mass with cystic components and microcalcification. (B) ABVS image revea
misdiagnosed as malignancy. (C) UE image reveals almost entire lesion as
eosin (H&E) image reveals intact ductal lining with papillary structures (orig
breast volume scanner. UE: US elastography.malignant. The interpretation of images was done in
same fashion as mentioned above.
Statistical analysis
Kappa statistics was used to interpret the concordance be-
tween examiners with ABVS and UE, and the concordance
between pathology and ABVS, UE, and the combination of
these two methods. The values of κ <0 indicates no agree-
ment, κ 0–0.20 slight, κ 0.21-0.40 fair, κ 0.41-0.60 moderate,
κ 0.61-0.80 substantial, and κ 0.81-1.00 almost perfect
agreement [25]. The accuracy, sensitivity, specificity, PPV
and NPP were calculated, and χ2 test was used to compare
diagnostic performance among these three methods. Statis-
tical significance was assumed as P < 0.05 for all tests. The
software package SPSS statistics version 16.0 (SPSS Inc,
Chicago, USA) was used for the statistical analysis.
Results
ABVS
In our study, 46 lesions in 41 patients were evaluated by
two examiners independently. According to examiner 1,
none of the lesions was rated as BI-RADS 1, 7 lesions as
BI-RADS 2, 8 lesions as BI-RADS 3, 19 lesions as BI-
RADS 4 and 12 lesions as BI-RADS 5. Overall, 15 le-
sions were rated as benign and 31 lesions as malignant.
As to examiner 2, none of the lesions was rated as BI-oman with intraductal papilloma. (A) US image reveals hypoecho
ls mass with microcalcifications within the duct (arrow), which was
red, indicating a hard lesion with UE score of 5. (D) Hemotoxylin and
inal magnification, × 200). US: Ultrasonography. ABVS: Automated
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3, 25 lesions as BI-RADS 4 and 7 lesions as BI-RADS 5.
In general, 14 lesions were rated as benign and 32
lesions as malignant. There was a substantial agreement
(κ = 0.62, 95% CI: 0.44-0.80) between examiner 1 and
examiner 2 (Table 2).
Looking closely at the results of ABVS, lesions of
BI-RADS 4 and BI-RADS 5 were in major differences
between examiner 1 and examiner 2. After discussion,
examiners got consistent results (Table 3) for the pur-
pose of better compared with the pathological category.
Kappa statistics was used to analyze the agreement
between final ABVS results and pathological findings,
which reached an almost perfect agreement (κ = 0.810
(95% CI: 0.64-0.98) (Table 4).
UE
Of the 46 lesions, examiner 1 graded none of the lesions
with a score of 1, 9 lesions a score of 2, 7 lesions a score
of 3, 26 lesions a score of 4, 4 lesions a score of 5. With
respect to examiner 2, none of the lesions had a score of
1, 8 lesions had a score of 2, 11 lesions had a score of 3,
18 lesions had a score of 4, 9 lesions had a score of 5.Figure 2 US, UE, ABVS and histologic section image in a 41-year-old w
nonpalpable lesion. (B) ABVS image shows retraction phenomenon as “cra
hard lesion with UE score of 5. (D) Hemotoxylin and eosin (H&E) image sho
vacuolation, clumping of nuclear chromatin (original magnification, × 200).
US elastography.There were 19 benign lesions and 27 malignant lesions
determined by examiner 1 while 16 benign lesions and
30 malignant lesions were determined by examiner 2.
The inter-examiner reliability obtained a substantial
agreement (κ = 0.65, 95% CI: 0.48-0.82) (Table 5).
Based on the result, lesions with a score of 3, 4, and
5 were not very consistent between examiner 1 and
examiner 2. To avoid discrepancy, two examiners had
another check together and eventually reached an agree-
ment on the results (Table 3). The results were further
compared with pathological findings. The inter-rater re-
liability demonstrated a substantial agreement (κ = 0.77,
95% CI: 0.58-0.96) (Table 4).
ABVS combined with UE
On the basis of complementary advantages, after the
interpretation of ABVS and UE images were completed,
the information of ABVS image and UE image were
provided for the two examiners to make comprehensive
assessment of all lesions. They redefined the category of
ABVS and the score of UE of every lesion and identified
the nature of lesions with both the morphological and
the stiffness details. Therefore, the diagnosed accuracyoman with invasive ductal carcinoma. (A) US image shows
ter” sign (arrow). (C) UE image shows entire lesion as red, indicating a
ws microstructure in tumor including cytoplasmic and nuclear
US: Ultrasonography. ABVS: Automated breast volume scanner. UE:
Xu et al. BMC Cancer 2014, 14:798 Page 6 of 10
http://www.biomedcentral.com/1471-2407/14/798would be increased (Table 3). The final results were
compared with pathological findings (Table 4), which
reached a perfect agreement (κ = 0.90, 95% CI: 0.77-1.00).
Pathology
All the lesions were biopsied using the 16G core needle
after the patients signed the consented form. Patho-
logical findings determined that 18 benign lesions were
6 mammary dysplasia, 8 fibroadenoma, and 4 intraductal
papilloma (Figure 1) and that 28 malignant lesions con-
sisted of 27 invasive ductal carcinoma (Figure 2) and 1
invasive cribriform carcinoma (Table 3).
Diagnosis performance
Compare BI-RADS category with pathological results, there
were 14 (14/18) benign lesions consistent with pathological
results and the malignant lesions were 28 (32/28), 4 benign
lesions were misdiagnosed as malignant lesions (Figure 3).
As respect to the UE results, 14 benign lesions and 27 ma-
lignant lesions were correctly diagnosed while 1 malignant
lesion was misdiagnosed as benign and 4 benign lesions
misdiagnosed as malignant (Figure 4). When ABVS and UE
combined, only two benign lesions were misdiagnosed as
malignant lesions (Figure 5). According to these results, theFigure 3 Categories of ABVS and pathological findings. Numbers in th
ABVS: Automated breast volume scanner. MD: mammary dysplasia. FA: fibro
ICC: invasive cribriform carcinoma.accuracy, sensitivity, specificity, PPN and NPN of ABVS,
UE, and ABVS combined with UE were calculated.
Though there were no statistically significance in any of
the diagnostic performance index among these three
methods, the accuracy, sensitivity, specificity, PPN and
NPN for ABVS combined with UE were 95.7% (95% CI:
84.0-99.2), 100% (95% CI: 85.9-100), 87.5% (95% CI: 60.4-
97.8), 93.8% (95% CI: 77.8-98.9), 100% (95% CI: 73.2-100),
for UE were 89.1% (95% CI: 75.6-95.9), 96.4% (95% CI:
79.8-99.8), 77.8% (95% CI: 51.9-92.6), 87.1% (95% CI: 69.2-
95.8), 93.3% (95% CI: 66.0-99.7), for ABVS were 91.3%
(95% CI: 78.3-97.2), 100% (95% CI: 85.0-1.00), 77.8% (95%
CI: 51.9-92.6), 87.5% (95% CI: 70.1-95.9), 100% (95% CI:
73.2-100), respectively, suggesting that the diagnostic per-
formance of ABVS combined with UE was better than, or
at least equal to, that of ABVS or UE alone (Table 6).
Discussion
Combined use of ABVS and UE for breast lesions is feasible
To our knowledge, this is the first report on combined
use of ABVS and UE for evaluation of benign and malig-
nant lesions of breast. The ability of ABVS to image
large benign and malignant lesions automatically and
UE to determine lesions stiffness effectively led to thee chart represent the number of lesions. 4 lesions were misdiagnosed.
adenoma. IP: intraductal papilloma. IDC: invasive ductal carcinoma.
Figure 4 Scores of UE and pathological findings. Numbers in the chart represent the number of lesions. 4 lesions were misdiagnosed. UE: US
elastography MD: mammary dysplasia. FA:fibroadenoma. IP:intraductal papilloma. IDC: invasive ductal carcinoma. ICC: invasive cribriform
carcinoma.
Figure 5 The numbers of lesions correctly diagnosed and misdiagnosed by ABVS, UE, and ABVS + UE. There were 4 lesions misdiagnosed
by both ABVS and UE, 2 lesions misdiagnosed by ABVS + UE. ABVS: Automated breast volume scanner. UE: US elastography.
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Table 6 Diagnostic performance of ABVS, UE, and ABVS + UE
Examina-tion Accuracy Sensitivity Specificity PPN NPN
95% CI 95% CI 95% CI 95% CI 95% CI
(P = 0.97) (P = 0.99) (P = 0.97) (P = 0.98) (P = 0.99)
ABVS 91.3% 100% 77.8% 87.5% 100%
78.3-97.2 85.0-100 51.9-92.6 70.1-95.9 73.2-1.00
UE 89.1% 96.4% 77.8% 87.1% 93.3%
75.6-95.9 79.8-99.8 51.9-92.6 69.2-95.8 66.0-99.7
ABVS + UE 95.7% 100% 87.50% 93.8% 100%
84.0-99.2 85.9-100 60.4-97.8 77.8-98.9 73.2-1.00
The diagnostic performance of ABVS, UE and ABVS + UE was evaluated.
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is capable of detecting clinically occult benignancy and
malignancy. This implies that the combination of ABVS
and UE seems to be a promising tool to overcome the
short comes of HHUS, ABVS, or UE when used alone,
though its agreement rate and the diagnostic perform-
ance are in small increments. We propose that this may
be because ABVS is inability to immediately adjust the
modifying factors such as compression, the orientation
of the probe, and the machine’s setting while acquiring
the image in real-time when exploring further a ques-
tionable lesion. Though HHUS and UE may compensate
these shortcomings, HHUS is lacking of standardization
in diagnostic for the poor reproducibility of images and
high variability of operators. And UE is not specific
enough to diagnose lesions in morphology. On the other
hand, both ABVS and UE are inability to perform color
or spectral Doppler for tissue or lesion vascularity.
Therefore, the combination of ABVS and UE provides
minimal benefit to diagnostic performance.
Excellent reproducibility
From a methodological point of view, agreement rate is
an indicator for a new, experimental diagnostic method
[11]. According to our results, ABVS and UE both
displayed substantial inter-examiner agreement (ABVS:
κ = 0.62, UE: κ = 0.65). The agreement among ABVS,
UE, and ABVS combined with UE with pathological
results were substantial or perfect (ABVS: κ = 0.81; UE:
κ = 0.77; ABVS + UE: κ = 0.90). Deservedly, ABVS com-
bined with UE showed a modest increase. Our results
are consistent with literatures showing an acceptable
range inter-examiner agreement of 0.18-0.80 on ABVS
[12,13,15] and 0.48-0.75 on UE [20,22,26]. These vari-
ation ranges may be accounted for reproducibility of
each method, characteristic of lesions and experience of
examiners. ABVS is known for its ability to reconstruct
and preserve high resolution and real-time images
simultaneously, and then to playback the image data in
the system, which corroborates an excellent reproduci-
bility. However, examiners’ experiences and lesions’features are uncontrollable factors. The senior ultra-
sound doctors are more sensitive to lesions and far more
likely to make the correct diagnosis than the junior
doctors, especially in regards to the benign lesions with
small diameter and limited specificity [13]. On the other
hand, UE, which has a simpler scoring system as BI-
RADS category, demonstrated a slightly increased reli-
ability of inter-examiners than ABVS. However, elasticity
images are vulnerable to mechanical properties, and elas-
tographic scanning parameters including applied strain,
transducer frequency, band width, and radiofrequency
sampling rate. Furthermore, the thickness of the breast
and the depth of the lesions play a decisive role on the
quality of elasticity images, which could affect the diag-
nostic performance significantly. While the thicker
breast and deeper lesions produce low quality images
and the less thickness breast and shallower lesions pro-
duce higher image quality [26,27]. Our data suggest that
ABVS combined with UE is a more practically useful
method for diagnosis. We speculated that doctors with
more than 10 years experience, patients (Asian women)
with small chest, lesions with palpable consistency, a
simple scoring system and advanced equipment were
the major factors for improving the quality of images
and minimizing the variability of inter-examiner to
ensure the diagnostic performance.
High diagnosis performance
With the good reproducibility and high agreement rate,
ABVS, UE, and ABVS combined with UE are proven to
have high diagnosis performance of detecting breast le-
sions and differentiating benign from malignant lesions.
Significant amount of literatures have validated that ABVS
has good diagnostic performance with accuracy of 66%-
97%, specificity of 52.8%-95%, sensitivity of 82%-100%
[11-17] and UE with sensitivity of 78.0%-100%, specificity
of 21.0%-98.5% [19,20]. Our study showed that diagnostic
performance of ABVS combined with UE (95.7% accuracy,
100% sensitivity, 87.5% specificity, 93.8% PPV, 100% NPN)
was slightly higher than UE (89.1% accuracy, 96.4% sensi-
tivity, 77.8% specificity, 87.1% PPV, 93.3% NPN) or ABVS
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PPV, 100% NPN) alone. Though there was no statistical
significance between ABVS combined with UE and ABVS
or UE alone, ABVS combined with UE was favorable to
improve the diagnostic performance.
Limitations
There are several limitations of our study. The first is
the lacking of comparison with HHUS. According to the
data reported, the diagnosis performance of ABVS or
UE was better than, or at least equal to, that of HHUS
[11-17,19,20]. These were great results convinced us that
ABVS or UE would be a practical method in detecting
breast lesions even HHUS was not being used. In fact,
ABVS and UE are simple and convenient methods with
their striking practical advantages of time saving, less
technical training, low variability and high reproducibil-
ity. Unsurprisingly, we got the results as expected and
consistent with the literatures. However, the experimen-
tal design would be improved if we compared them with
HHUS. Second, the sample size was small. Among 46
lesions, there was no ductal carcinoma in situ (DCSI).
Undoubtedly, microcalcifications would mostly appear
on DCSI. The high resolution image of ABVS can pro-
vide better demonstration of breast anatomy and proper
orientation. It makes it possible for identifying microcal-
cifications of ductal carcinoma in situ (DCSI). If we had
samples of DCSI, our results might have varied. Third,
we didn’t use Color Doppler ultrasound to analyze the
vascularity of the lesions. This is able to provide blood
supply and resistant index for identifying benign or ma-
lignant lesions. We didn’t apply strain ratio to evaluate
the lesion stiffness either, which could be used as an
objective and constant characteristic regardless of data
acquisition or interpretation variability [28]. In addition,
strain ratio can determine whether a lesion is benign or
malignant [29]. In our study, two benign lesions (one
was fibroadenoma, another was intraductal papilloma
(Figure 1)) both with little spiculated margin on ABVS
and almost the entire lesion in red on UE, we misinter-
preted as malignancy. According to report [30], if the
diameter of fibroadenoma was large, it may manifest
itself with irregular lobulation, speculation and foliar
margins. It is difficult to distinguish benign from malig-
nant lesions. In this situation, we recommend a needle
aspiration or excision biopsy for a histologic diagnosis.
Referring to intraductal papilloma, it shows a diversity of
histopathological features usually accompanied by intra-
ductal hyperplasia, atypical ductal hyperplasia, DCIS,
and even IDC. This led to variation of clinical features.
Therefore, with these two benign lesions’ indeterminate
characteristics, diagnosis is difficult and shows no sign
of becoming easier [31]. It is not surprising that
we made a misdiagnosis. However, if Color Dopplerultrasound and strain ratio could be used to conduct
further analysis and review, more information would be
available. Unfortunately, lack of the evaluation of vascu-
larity is what the shortcoming of ABVS and UE [9].
Conclusions
In conclusion, the results of our study show that both
ABVS and UE demonstrated substantial inter-examiner
reliability. With the advantages of good reproducibility,
low variability, less operator training, time saving of
ABVS, and the strength of simpler scoring system and
operation procedure of UE, and combining these two
methods would be favorable to improve diagnostic
accuracy and specificity.
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